Daisuke Tanaka Director, Venture Support Office
Economic Affairs Division
Health Policy Bureau Ministry of Health, Labour and Welfare (MHLW), Japan

Yasuo Iimura Director for Policy Planning, Healthcare Industries Division, Commerce and Service Industry Policy Group Ministry of Economy, Trade and Industry

Christophe Weber President, Chief Executive Officer (CEO) and Representative Director Takeda Pharmaceutical Co., Ltd.

Ole Moelskov Bech President and Representative Director Novo Nordisk Pharma AG

Tomohiro Kuroda CIO / Professor, Hospital Kyoto University

Hiroshi Nishiura Professor, Graduate School of Medicine Kyoto University

Eiji Aramaki Professor, Social Computing Laboratory Nara Institute of Science and Technology (NAIST)

Jovelle L. Fernandez, MD, PhD, FPOGS Head
Japan Medical Office
Japan Pharma Business Unit Takeda Pharmaceutical Co., Ltd.

Susie Barnes Member of the Board, Country Medical Director
VP and Head of Japan Medical and Development GlaxoSmithKline K.K.

Makoto Sugita Executive Officer, Vice President, R&D Japan Bristol Myers Squibb

Naotsugu Oyama Corporate Officer Head, Clinical Development&Analytics Japan, Global Drug Development Division Novartis Pharma K.K.

Takafumi Horii Senior Vice President, Head of Japan Oncology Business Unit, Global Oncology Business Unit Takeda Pharmaceutical Co., Ltd.

Jumpei Soeda Head, Japan Medical Affairs, Japan Oncology Business Unit Takeda Pharmaceutical Co., Ltd.

Junko Kimura Sr. Director, Commercial Operations Gilead Sciences K.K.

Hideko Ikeda Managing Director Merck Vietnam Company

Ko Ishiyama President & CEO ExaWizards Inc.

Yasuyuki Katayama Associate Vice President/ Head of Medical Affairs/ Executive Officer MSD Japan

Manabu Muto Professor / Head, Department of Therapeutic Oncology, Graduate School of Medicine / Department of Clinical Oncology Kyoto University Hospital (Japan)

Takanori Takebe Professor, Founding director, Institute of Research, Communication Design Center; Advanced Medical Research Center Tokyo Medical and Dental University, Yokohama City University

Masahisa Jinushi Head of Oncology Medical, Medical Division AstraZeneca K.K.

Kazuo Hasegawa Founder Lung Cancer Patients Network ONE STEP

Kazuhiko Nakagawa Professor, Department of Medical Oncology Kindai University Faculty of Medicine

Masaru Otsuka Strategic Digital Japan Head, Enterprise Digital Takeda Pharmaceutical Co., Ltd.

Shinya Suda Senior Vice President, Information Systems Astellas Pharma Inc.

Masatoshi Morita Head of Japan, Bone Health Mission UCB Japan

Masayuki Katsumata Head, Value Evidence & Outcomes, Japan Medical and Development GlaxoSmithKline Japan

Kenichi Nakamura Director, Department of International Clinical Development National Cancer Center Hospital

Kyoichi Nishimoto Head, Customer Engagement Innovation Amgen K.K.

Kotonari Aoki Department Manager, Real World Data Science Dept. Chugai Pharmaceutical Co.,Ltd.

Osamu Komiyama Senior Manager, Statistical Research & Data Science Group Pfizer R&D Japan

Hiroyuki Taruno Japanese Foundation For Cancer Research
Cancer Institute Hospital

Seigo Noda Marketing Senior Director, Renal, CVRM/GI Business Unit AstraZeneca KK

Tomoo Miyake Director, Sales Planning, Liver Business Unit, Japan Gilead Sciences K.K.

Takashi Moriya Director, Evidence Generation, Medical Affairs Janssen Pharmaceutical K.K.

Hideyuki Shiba Director, Medical Excellence AstraZeneca K.K.

Kenichiro Shimizu Japan Medical Affairs Director, Abbott Diabetes Care, Japan Medical Affairs Abbott Japan LLC

Keiko Yokoyama Senior Manager, Japan Data Sciences, Scientific Data Solutions and Communications, MDU-Japan Eli Lilly Japan K.K.

Taruho Kuroda Senior Director, LEO Science & Tech Hub LEO Pharma

Kanae Togo Senior Manager, Outcome & Evidence, Health & Value Pfizer Japan Inc.

Hiroyuki Higashiyama Director, Patient Centricity Astellas Pharma Inc.

Daisuke Kojo Director, Government Affairs Eli Lilly Japan K.K.

Maya Mamiya Senior Manager, Government Affairs, Corporate Affairs Eli Lilly Japan K.K.

Donatas Grabliauskas Marketing & Strategic Liaison Director, Oncology business unit Johnson & Johnson

Norihiro Kobayashi Director, Digital Intelligence Dept. SHIONOGI & CO., LTD.

Atsushi Yamashita Director, Customer Engagement Transformation, Commercial Excellence AstraZeneca K.K.

Misaki Ohkawara Group Manager/Business relationship Manager, Digital Transformation Group, Information & Digital Solutions AstraZeneca K.K.

Takeshi Shukunobe CEO PPEC (General Incorporated Association)

Hiromi Todoroki Chair（Chairwoman） Certified non-profit organization KIBONOKAI (Bring Ray of Hope)

Rob Arnold Executive Vice President EVERSANA

Motohide Nishi VP, Japan Professional Services Medidata

Kazuaki Hayata Senior Manager, Healthcare & Life Sciences Industry, Industries Transformation salesforce.com, Inc.

Joeri De Haes Director Japan & Asia Pacific, Market Strategies Trilations

Miyuki Baillie Vice President, Science Group, Japan Clarivate

Satoshi Yoshizumi Sr. Clinical Operations Leader Parexel International

Yuji Fujii Senior Client Relationship Director, Enterprise Accounts Japan Parexel International

Yoshinori Abe MD, Co-Founder & CEO Ubie, Inc.

Ken Hersche Senior Director, Client Success Within3

Akira Oka Business Development Ubie, Inc.

Peter de Jong Global Director, Health, Corporate Sales Wiley

Hirotaka Nagashima Director, Center Manager, Clinical Research Center Tokyo Center Clinic, Medical Corporation Chiseikai

Shigehiro Miki Representative Director, General Manager - Japan Parexel International